Establishment and characterization of human malignant lymphoma cell line derived from uterine cervix

Area of Science:

• Oncology
• Cell Biology
• Virology

Background:

• Malignant lymphoma of the uterine cervix is a rare but aggressive hematologic malignancy.
• Establishing and characterizing novel cell lines is crucial for understanding disease mechanisms and developing targeted therapies.

Purpose of the Study:

• To establish and characterize a new human uterine cervical malignant lymphoma (B-cell type) cell line.
• To evaluate the tumorigenicity of the established cell line in vivo.
• To investigate the presence of Epstein-Barr virus in the cell line.

Main Methods:

• Cell culture of human uterine cervical malignant lymphoma (B-cell type).
• Morphological and proliferation assessments of the established cell line (HIUML).
• Tumorigenicity assays in nude mice and hamsters.
• Epstein-Barr virus detection.

Main Results:

• A novel cell line, HIUML, was successfully established from human uterine cervical malignant lymphoma (B-cell type).
• HIUML cells exhibited round morphology, formed floating clusters, and proliferated in suspension with a population doubling time of approximately 32 hours.
• The cell line maintained characteristics over 42 passages and formed malignant lymphomas in hamster cheek pouches but not in nude mice.
• Epstein-Barr virus was detected in the HIUML cells.

Conclusions:

• The HIUML cell line represents a valuable new model for studying human uterine cervical malignant lymphoma (B-cell type).
• The successful xenotransplantation in hamsters provides a platform for preclinical drug testing and disease modeling.
• The presence of Epstein-Barr virus suggests a potential role in the pathogenesis of this specific lymphoma subtype.